AAAAAA

   
Results: 1-14 |
Results: 14
Radioiodine uptake and thyroid scintiscanning
Authors: Meier, DA Kaplan, MM
Citation: Da. Meier et Mm. Kaplan, Radioiodine uptake and thyroid scintiscanning, END METAB C, 30(2), 2001, pp. 291
Heterogeneous response of antimitochondrial autoantibodies and bile duct apical staining monoclonal antibodies to pyruvate dehydrogenase complex E2: The molecule versus the mimic
Authors: Migliaccio, C Van de Water, J Ansari, AA Kaplan, MM Coppel, RL Lam, KS Thompson, RK Stevenson, F Gershwin, ME
Citation: C. Migliaccio et al., Heterogeneous response of antimitochondrial autoantibodies and bile duct apical staining monoclonal antibodies to pyruvate dehydrogenase complex E2: The molecule versus the mimic, HEPATOLOGY, 33(4), 2001, pp. 792-801
Living-donor versus cadaveric liver transplantation for non-resectable small hepatocellular carcinoma and compensated cirrhosis: A decision analysis.
Authors: Cheng, SJ Pratt, DS Freeman, RB Kaplan, MM Wong, JB
Citation: Sj. Cheng et al., Living-donor versus cadaveric liver transplantation for non-resectable small hepatocellular carcinoma and compensated cirrhosis: A decision analysis., TRANSPLANT, 72(5), 2001, pp. 861-868
Is liver fibrosis reversible?
Authors: Bonis, PAL Friedman, SL Kaplan, MM
Citation: Pal. Bonis et al., Is liver fibrosis reversible?, N ENG J MED, 344(6), 2001, pp. 452-454
Elevated liver enzymes in asymptomatic patients - Reply
Authors: Pratt, DS Kaplan, MM
Citation: Ds. Pratt et Mm. Kaplan, Elevated liver enzymes in asymptomatic patients - Reply, N ENG J MED, 343(9), 2000, pp. 663-663
Primary care: Evaluation of abnormal liver-enzyme results in asymptomatic patients.
Authors: Pratt, DS Kaplan, MM
Citation: Ds. Pratt et Mm. Kaplan, Primary care: Evaluation of abnormal liver-enzyme results in asymptomatic patients., N ENG J MED, 342(17), 2000, pp. 1266-1271
The efforts of WHO and Pugwash to eliminate chemical and biological weapons - a memoir
Authors: Kaplan, MM
Citation: Mm. Kaplan, The efforts of WHO and Pugwash to eliminate chemical and biological weapons - a memoir, B WHO, 77(2), 1999, pp. 149-155
Low-dose methotrexate in primary biliary cirrhosis
Authors: Bonis, PAL Kaplan, MM
Citation: Pal. Bonis et Mm. Kaplan, Low-dose methotrexate in primary biliary cirrhosis, GASTROENTY, 117(6), 1999, pp. 1510-1511
A prospective trial of colchicine and methotrexate in the treatment of primary biliary cirrhosis
Authors: Kaplan, MM Schmid, C Provenzale, D Sharma, A Dickstein, G McKusick, A
Citation: Mm. Kaplan et al., A prospective trial of colchicine and methotrexate in the treatment of primary biliary cirrhosis, GASTROENTY, 117(5), 1999, pp. 1173-1180
Clinical perspectives in the diagnosis of thyroid disease
Authors: Kaplan, MM
Citation: Mm. Kaplan, Clinical perspectives in the diagnosis of thyroid disease, CLIN CHEM, 45(8B), 1999, pp. 1377-1383
Clinical perspectives in the diagnosis of thyroid disease
Authors: Kaplan, MM
Citation: Mm. Kaplan, Clinical perspectives in the diagnosis of thyroid disease, CLIN CHEM, 45(8), 1999, pp. 1377-1383
Management of primary biliary cirrhosis
Authors: Lee, YM Kaplan, MM
Citation: Ym. Lee et Mm. Kaplan, Management of primary biliary cirrhosis, CLIN G MED, 1999, pp. 139-147
Regression of hepatic fibrosis in hepatitis C with long-term interferon treatment
Authors: Dufour, JF DeLellis, R Kaplan, MM
Citation: Jf. Dufour et al., Regression of hepatic fibrosis in hepatitis C with long-term interferon treatment, DIG DIS SCI, 43(12), 1998, pp. 2573-2576
Iron chelation with oral deferiprone in patients with thalassemia
Authors: Kowdley, KV Kaplan, MM
Citation: Kv. Kowdley et Mm. Kaplan, Iron chelation with oral deferiprone in patients with thalassemia, N ENG J MED, 339(23), 1998, pp. 1714-1714
Risultati: 1-14 |